In the last trading session, 1.9 million Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) shares changed hands as the company’s beta touched 0.96. With the company’s per share price at $15.74 changed hands at $0.03 or 0.19% during last session, the market valuation stood at $2.17B. ARWR’s last price was a discount, traded about -93.2% off its 52-week high of $30.41. The share price had its 52-week low at $9.57, which suggests the last value was 39.2% up since then.
Analysts gave the Arrowhead Pharmaceuticals Inc (ARWR) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.62. If we narrow down to specifics, the data shows that 0 out of 9 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 3 recommended ARWR as a Hold, 6 felt it is a Buy and 0 rated the stock as Underweight.
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) trade information
Instantly ARWR was in green as seen at the end of in last trading. With action 12.67%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -16.28%, with the 5-day performance at 12.67% in the green. However, in the 30-day time frame, Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) is 40.04% up.
The consensus price target for the stock as assigned by Wall Street analysts is 26.98, meaning bulls need an upside of 41.66% from its current market value. According to analyst projections, ARWR’s forecast low is 24 with 29.97 as the target high. To hit the forecast high, the stock’s price needs a -90.41% plunge from its current level, while the stock would need to soar -52.48% for it to hit the projected low.
Arrowhead Pharmaceuticals Inc (ARWR) estimates and forecasts
The 2025 estimates are for Arrowhead Pharmaceuticals Inc earnings to increase by 103.40%, but the outlook for the next 5-year period is at 9.12% per year.
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)’s Major holders
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 9.8343% or 12.21 million shares worth $317.44 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund. With 7.85 shares estimated at $123.49 million under it, the former controlled 5.68% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 2.65% of the shares, roughly 3.66 shares worth around $57.65 million.
